{"transactions":[{"id":4638373,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-10-09T01:59:35.000Z","date":"2026-10-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":256000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the disposition of shares of common stock (\"Common Stock\") of BioLife Solutions, Inc. (the \"Registrant\") in connection with the consummation on October 6, 2026 of the merger of Bravo Merger Sub I, Inc., a Delaware corporation (\"Merger Sub 1\") with and into the Registrant (the \"First Merger\"), pursuant to the Agreement and Plan of Merger, dated as of July 21, 2026 (the \"Merger Agreement\"), by and among the Registrant, Repligen Corporation, a Delaware corporation (\"Repligen\"), Merger Sub 1 and Bravo Merger Sub II, LLC, a Delaware limited liability company. At the effective time of the First Merger (the \"First Merger Effective Time\"), each outstanding share of Common Stock was converted into the right to receive $11.25 in cash and 0.1442 shares of Repligen common stock, in each case subject to the terms and conditions of the Merger Agreement."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-418329","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1892616/000119312526418329/ownership.xml","form_type":"4"}},{"id":4638372,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-10-09T01:59:35.000Z","date":"2026-10-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":95933,"price":38.61,"value":3703973.13,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents shares withheld to cover tax withholding obligations in connection with the vesting of the market-based restricted stock award."}],"balance_after":183248,"source":{"system":"sec-edgar","filing":"0001193125-26-418329","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1892616/000119312526418329/ownership.xml","form_type":"4"}},{"id":4638371,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-10-09T01:59:35.000Z","date":"2026-10-06","kind":"grant","planned":false,"acquired":true,"shares":62300,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The restricted stock was granted pursuant to the 2023 Plan. In accordance with the terms of the grant and the Merger Agreement, the restricted stock vested immediately prior to the First Merger Effective Time as to approximately 200% of the number of shares granted based on the Registrant's total shareholder return during the period beginning on January 1, 2026 through October 2, 2026 as compared to the total shareholder return of certain of the Registrant's peers (such peers have been determined by the Registrant's compensation committee with assistance of an outside consultant immediately prior to the grant date)."}],"balance_after":279181,"source":{"system":"sec-edgar","filing":"0001193125-26-418329","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1892616/000119312526418329/ownership.xml","form_type":"4"}},{"id":4638370,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-10-09T01:59:35.000Z","date":"2026-10-06","kind":"grant","planned":false,"acquired":true,"shares":76204,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The restricted stock was granted pursuant to the BioLife Solutions 2023 Omnibus Performance Incentive Plan (the \"2023 Plan\"). In accordance with the terms of the grant and the Merger Agreement, the restricted stock vested immediately prior to the First Merger Effective Time as to approximately 200% of the number of shares granted based on the Registrant's total shareholder return during the period beginning on January 1, 2025 through October 2, 2026 as compared to the total shareholder return of certain of the Registrant's peers (such peers have been determined by the Registrant's compensation committee with assistance of an outside consultant immediately prior to the grant date)."}],"balance_after":216881,"source":{"system":"sec-edgar","filing":"0001193125-26-418329","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1892616/000119312526418329/ownership.xml","form_type":"4"}},{"id":4638374,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":64607,"kind":"person","name":"GOSWAMI JOYDEEP","position":1,"cik":"0001533115","reported_name":"GOSWAMI JOYDEEP","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-10-09T01:59:33.000Z","date":"2026-10-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":53156,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the disposition of shares of common stock (\"Common Stock\") of BioLife Solutions, Inc. (the \"Registrant\") in connection with the consummation on October 6, 2026 of the merger of Bravo Merger Sub I, Inc., a Delaware corporation (\"Merger Sub 1\") with and into the Registrant (the \"First Merger\"), pursuant to the Agreement and Plan of Merger, dated as of July 21, 2026 (the \"Merger Agreement\"), by and among the Registrant, Repligen Corporation, a Delaware corporation (\"Repligen\"), Merger Sub 1 and Bravo Merger Sub II, LLC, a Delaware limited liability company. At the effective time of the First Merger (the \"First Merger Effective Time\"), each outstanding share of Common Stock was converted into the right to receive $11.25 in cash and 0.1442 shares of Repligen common stock, in each case subject to the terms and conditions of the Merger Agreement."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-418328","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533115/000119312526418328/ownership.xml","form_type":"4"}},{"id":4638369,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":64609,"kind":"person","name":"Ellingson Rachel","position":1,"cik":"0001557271","reported_name":"Ellingson Rachel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-10-09T01:59:10.000Z","date":"2026-10-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":57995,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the disposition of shares of common stock (\"Common Stock\") of BioLife Solutions, Inc. (the \"Registrant\") in connection with the consummation on October 6, 2026 of the merger of Bravo Merger Sub I, Inc., a Delaware corporation (\"Merger Sub 1\") with and into the Registrant (the \"First Merger\"), pursuant to the Agreement and Plan of Merger, dated as of July 21, 2026 (the \"Merger Agreement\"), by and among the Registrant, Repligen Corporation, a Delaware corporation (\"Repligen\"), Merger Sub 1 and Bravo Merger Sub II, LLC, a Delaware limited liability company. At the effective time of the First Merger (the \"First Merger Effective Time\"), each outstanding share of Common Stock was converted into the right to receive $11.25 in cash and 0.1442 shares of Repligen common stock, in each case subject to the terms and conditions of the Merger Agreement."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-418327","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1557271/000119312526418327/ownership.xml","form_type":"4"}},{"id":4638368,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":64611,"kind":"person","name":"DuRoss Amy","position":1,"cik":"0001854968","reported_name":"DuRoss Amy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-10-09T01:59:00.000Z","date":"2026-10-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":26857,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the disposition of shares of common stock (\"Common Stock\") of BioLife Solutions, Inc. (the \"Registrant\") in connection with the consummation on October 6, 2026 of the merger of Bravo Merger Sub I, Inc., a Delaware corporation (\"Merger Sub 1\") with and into the Registrant (the \"First Merger\"), pursuant to the Agreement and Plan of Merger, dated as of July 21, 2026 (the \"Merger Agreement\"), by and among the Registrant, Repligen Corporation, a Delaware corporation (\"Repligen\"), Merger Sub 1 and Bravo Merger Sub II, LLC, a Delaware limited liability company. At the effective time of the First Merger (the \"First Merger Effective Time\"), each outstanding share of Common Stock was converted into the right to receive $11.25 in cash and 0.1442 shares of Repligen common stock, in each case subject to the terms and conditions of the Merger Agreement."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-418325","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854968/000119312526418325/ownership.xml","form_type":"4"}},{"id":4638367,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":64610,"kind":"person","name":"Coste Catherine","position":1,"cik":"0001821432","reported_name":"Coste Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-10-09T01:58:49.000Z","date":"2026-10-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":13871,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the disposition of shares of common stock (\"Common Stock\") of BioLife Solutions, Inc. (the \"Registrant\") in connection with the consummation on October 6, 2026 of the merger of Bravo Merger Sub I, Inc., a Delaware corporation (\"Merger Sub 1\") with and into the Registrant (the \"First Merger\"), pursuant to the Agreement and Plan of Merger, dated as of July 21, 2026 (the \"Merger Agreement\"), by and among the Registrant, Repligen Corporation, a Delaware corporation (\"Repligen\"), Merger Sub 1 and Bravo Merger Sub II, LLC, a Delaware limited liability company. At the effective time of the First Merger (the \"First Merger Effective Time\"), each outstanding share of Common Stock was converted into the right to receive $11.25 in cash and 0.1442 shares of Repligen common stock, in each case subject to the terms and conditions of the Merger Agreement."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-418323","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1821432/000119312526418323/ownership.xml","form_type":"4"}},{"id":4638366,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":36550,"kind":"person","name":"DE GREEF RODERICK","position":1,"cik":"0001241181","reported_name":"DE GREEF RODERICK","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-10-09T01:58:27.000Z","date":"2026-10-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":826454,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the disposition of shares of common stock (\"Common Stock\") of BioLife Solutions, Inc. (the \"Registrant\") in connection with the consummation on October 6, 2026 of the merger of Bravo Merger Sub I, Inc., a Delaware corporation (\"Merger Sub 1\") with and into the Registrant (the \"First Merger\"), pursuant to the Agreement and Plan of Merger, dated as of July 21, 2026 (the \"Merger Agreement\"), by and among the Registrant, Repligen Corporation, a Delaware corporation (\"Repligen\"), Merger Sub 1 and Bravo Merger Sub II, LLC, a Delaware limited liability company. At the effective time of the First Merger (the \"First Merger Effective Time\"), each outstanding share of Common Stock was converted into the right to receive $11.25 in cash and 0.1442 shares of Repligen common stock, in each case subject to the terms and conditions of the Merger Agreement."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-418321","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1241181/000119312526418321/ownership.xml","form_type":"4"}},{"id":4638365,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":36550,"kind":"person","name":"DE GREEF RODERICK","position":1,"cik":"0001241181","reported_name":"DE GREEF RODERICK","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-10-09T01:58:27.000Z","date":"2026-10-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":364872,"price":38.61,"value":14087707.92,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents shares withheld to cover tax withholding obligations in connection with the vesting of the market-based restricted stock award."}],"balance_after":439774,"source":{"system":"sec-edgar","filing":"0001193125-26-418321","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1241181/000119312526418321/ownership.xml","form_type":"4"}},{"id":4638364,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":36550,"kind":"person","name":"DE GREEF RODERICK","position":1,"cik":"0001241181","reported_name":"DE GREEF RODERICK","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-10-09T01:58:27.000Z","date":"2026-10-06","kind":"grant","planned":false,"acquired":true,"shares":237460,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The restricted stock was granted pursuant to the 2023 Plan. In accordance with the terms of the grant and the Merger Agreement, the restricted stock vested immediately prior to the First Merger Effective Time as to approximately 200% of the number of shares granted based on the Registrant's total shareholder return during the period beginning on January 1, 2026 through October 2, 2026 as compared to the total shareholder return of certain of the Registrant's peers (such peers have been determined by the Registrant's compensation committee with assistance of an outside consultant immediately prior to the grant date)."}],"balance_after":804646,"source":{"system":"sec-edgar","filing":"0001193125-26-418321","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1241181/000119312526418321/ownership.xml","form_type":"4"}},{"id":4638363,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":36550,"kind":"person","name":"DE GREEF RODERICK","position":1,"cik":"0001241181","reported_name":"DE GREEF RODERICK","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-10-09T01:58:27.000Z","date":"2026-10-06","kind":"grant","planned":false,"acquired":true,"shares":225670,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The restricted stock was granted pursuant to the BioLife Solutions 2023 Omnibus Performance Incentive Plan (the \"2023 Plan\"). In accordance with the terms of the grant and the Merger Agreement, the restricted stock vested immediately prior to the First Merger Effective Time as to approximately 200% of the number of shares granted based on the Registrant's total shareholder return during the period beginning on January 1, 2025 through October 2, 2026 as compared to the total shareholder return of certain of the Registrant's peers (such peers have been determined by the Registrant's compensation committee with assistance of an outside consultant immediately prior to the grant date)."}],"balance_after":567186,"source":{"system":"sec-edgar","filing":"0001193125-26-418321","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1241181/000119312526418321/ownership.xml","form_type":"4"}},{"id":4638362,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":38580,"kind":"person","name":"Hunt Anthony","position":1,"cik":"0001606030","reported_name":"Hunt Anthony","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-10-09T01:58:14.000Z","date":"2026-10-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":15046,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the disposition of shares of common stock (\"Common Stock\") of BioLife Solutions, Inc. (the \"Registrant\") in connection with the consummation on October 6, 2026 of the merger of Bravo Merger Sub I, Inc., a Delaware corporation (\"Merger Sub 1\") with and into the Registrant (the \"First Merger\"), pursuant to the Agreement and Plan of Merger, dated as of July 21, 2026 (the \"Merger Agreement\"), by and among the Registrant, Repligen Corporation, a Delaware corporation (\"Repligen\"), Merger Sub 1 and Bravo Merger Sub II, LLC, a Delaware limited liability company. At the effective time of the First Merger (the \"First Merger Effective Time\"), each outstanding share of Common Stock was converted into the right to receive $11.25 in cash and 0.1442 shares of Repligen common stock, in each case subject to the terms and conditions of the Merger Agreement."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-418319","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1606030/000119312526418319/ownership.xml","form_type":"4"}},{"id":4638357,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":64608,"kind":"person","name":"MOORE TIMOTHY L.","position":1,"cik":"0001669207","reported_name":"MOORE TIMOTHY L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-10-09T01:57:45.000Z","date":"2026-10-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":44943,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the disposition of shares of common stock (\"Common Stock\") of BioLife Solutions, Inc. (the \"Registrant\") in connection with the consummation on October 6, 2026 of the merger of Bravo Merger Sub I, Inc., a Delaware corporation (\"Merger Sub 1\") with and into the Registrant (the \"First Merger\"), pursuant to the Agreement and Plan of Merger, dated as of July 21, 2026 (the \"Merger Agreement\"), by and among the Registrant, Repligen Corporation, a Delaware corporation (\"Repligen\"), Merger Sub 1 and Bravo Merger Sub II, LLC, a Delaware limited liability company. At the effective time of the First Merger (the \"First Merger Effective Time\"), each outstanding share of Common Stock was converted into the right to receive $11.25 in cash and 0.1442 shares of Repligen common stock, in each case subject to the terms and conditions of the Merger Agreement."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-418316","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1669207/000119312526418316/ownership.xml","form_type":"4"}},{"id":4638361,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30886,"kind":"person","name":"Mathew Aby J.","position":1,"cik":"0001556355","reported_name":"Mathew Aby J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-10-09T01:57:42.000Z","date":"2026-10-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":404608,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the disposition of shares of common stock (\"Common Stock\") of BioLife Solutions, Inc. (the \"Registrant\") in connection with the consummation on October 6, 2026 of the merger of Bravo Merger Sub I, Inc., a Delaware corporation (\"Merger Sub 1\") with and into the Registrant (the \"First Merger\"), pursuant to the Agreement and Plan of Merger, dated as of July 21, 2026 (the \"Merger Agreement\"), by and among the Registrant, Repligen Corporation, a Delaware corporation (\"Repligen\"), Merger Sub 1 and Bravo Merger Sub II, LLC, a Delaware limited liability company. At the effective time of the First Merger (the \"First Merger Effective Time\"), each outstanding share of Common Stock was converted into the right to receive $11.25 in cash and 0.1442 shares of Repligen common stock, in each case subject to the terms and conditions of the Merger Agreement."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-418315","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1556355/000119312526418315/ownership.xml","form_type":"4"}},{"id":4638360,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30886,"kind":"person","name":"Mathew Aby J.","position":1,"cik":"0001556355","reported_name":"Mathew Aby J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-10-09T01:57:42.000Z","date":"2026-10-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":70000,"price":38.61,"value":2702700.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents shares withheld to cover tax withholding obligations in connection with the vesting of the market-based restricted stock award."}],"balance_after":314058,"source":{"system":"sec-edgar","filing":"0001193125-26-418315","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1556355/000119312526418315/ownership.xml","form_type":"4"}},{"id":4638359,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30886,"kind":"person","name":"Mathew Aby J.","position":1,"cik":"0001556355","reported_name":"Mathew Aby J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-10-09T01:57:42.000Z","date":"2026-10-06","kind":"grant","planned":false,"acquired":true,"shares":40192,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The restricted stock was granted pursuant to the 2023 Plan. In accordance with the terms of the grant and the Merger Agreement, the restricted stock vested immediately prior to the First Merger Effective Time as to approximately 200% of the number of shares granted based on the Registrant's total shareholder return during the period beginning on January 1, 2026 through October 2, 2026 as compared to the total shareholder return of certain of the Registrant's peers (such peers have been determined by the Registrant's compensation committee with assistance of an outside consultant immediately prior to the grant date)."}],"balance_after":384058,"source":{"system":"sec-edgar","filing":"0001193125-26-418315","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1556355/000119312526418315/ownership.xml","form_type":"4"}},{"id":4638358,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30886,"kind":"person","name":"Mathew Aby J.","position":1,"cik":"0001556355","reported_name":"Mathew Aby J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-10-09T01:57:42.000Z","date":"2026-10-06","kind":"grant","planned":false,"acquired":true,"shares":45838,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The restricted stock was granted pursuant to the BioLife Solutions 2023 Omnibus Performance Incentive Plan (the \"2023 Plan\"). In accordance with the terms of the grant and the Merger Agreement, the restricted stock vested immediately prior to the First Merger Effective Time as to approximately 200% of the number of shares granted based on the Registrant's total shareholder return during the period beginning on January 1, 2025 through October 2, 2026 as compared to the total shareholder return of certain of the Registrant's peers (such peers have been determined by the Registrant's compensation committee with assistance of an outside consultant immediately prior to the grant date)."}],"balance_after":343866,"source":{"system":"sec-edgar","filing":"0001193125-26-418315","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1556355/000119312526418315/ownership.xml","form_type":"4"}},{"id":4638356,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30885,"kind":"person","name":"Berard Todd","position":1,"cik":"0001633186","reported_name":"Berard Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Marketing Officer"}}],"security":"Common Stock","published_at":"2026-10-09T01:55:47.000Z","date":"2026-10-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":194786,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the disposition of shares of common stock (\"Common Stock\") of BioLife Solutions, Inc. (the \"Registrant\") in connection with the consummation on October 6, 2026 of the merger of Bravo Merger Sub I, Inc., a Delaware corporation (\"Merger Sub 1\") with and into the Registrant (the \"First Merger\"), pursuant to the Agreement and Plan of Merger, dated as of July 21, 2026 (the \"Merger Agreement\"), by and among the Registrant, Repligen Corporation, a Delaware corporation (\"Repligen\"), Merger Sub 1 and Bravo Merger Sub II, LLC, a Delaware limited liability company. At the effective time of the First Merger (the \"First Merger Effective Time\"), each outstanding share of Common Stock was converted into the right to receive $11.25 in cash and 0.1442 shares of Repligen common stock, in each case subject to the terms and conditions of the Merger Agreement."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-418308","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1633186/000119312526418308/ownership.xml","form_type":"4"}},{"id":4638355,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30885,"kind":"person","name":"Berard Todd","position":1,"cik":"0001633186","reported_name":"Berard Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Marketing Officer"}}],"security":"Common Stock","published_at":"2026-10-09T01:55:47.000Z","date":"2026-10-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":46170,"price":38.61,"value":1782623.7,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents shares withheld to cover tax withholding obligations in connection with the vesting of the market-based restricted stock award."}],"balance_after":156589,"source":{"system":"sec-edgar","filing":"0001193125-26-418308","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1633186/000119312526418308/ownership.xml","form_type":"4"}},{"id":4638354,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30885,"kind":"person","name":"Berard Todd","position":1,"cik":"0001633186","reported_name":"Berard Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Marketing Officer"}}],"security":"Common Stock","published_at":"2026-10-09T01:55:47.000Z","date":"2026-10-06","kind":"grant","planned":false,"acquired":true,"shares":40192,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The restricted stock was granted pursuant to the 2023 Plan. In accordance with the terms of the grant and the Merger Agreement, the restricted stock vested immediately prior to the First Merger Effective Time as to approximately 200% of the number of shares granted based on the Registrant's total shareholder return during the period beginning on January 1, 2026 through October 2, 2026 as compared to the total shareholder return of certain of the Registrant's peers (such peers have been determined by the Registrant's compensation committee with assistance of an outside consultant immediately prior to the grant date)."}],"balance_after":202759,"source":{"system":"sec-edgar","filing":"0001193125-26-418308","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1633186/000119312526418308/ownership.xml","form_type":"4"}},{"id":4638353,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30885,"kind":"person","name":"Berard Todd","position":1,"cik":"0001633186","reported_name":"Berard Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Marketing Officer"}}],"security":"Common Stock","published_at":"2026-10-09T01:55:47.000Z","date":"2026-10-06","kind":"grant","planned":false,"acquired":true,"shares":38198,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The restricted stock was granted pursuant to the BioLife Solutions 2023 Omnibus Performance Incentive Plan (the \"2023 Plan\"). In accordance with the terms of the grant and the Merger Agreement, the restricted stock vested immediately prior to the First Merger Effective Time as to approximately 200% of the number of shares granted based on the Registrant's total shareholder return during the period beginning on January 1, 2025 through October 2, 2026 as compared to the total shareholder return of certain of the Registrant's peers (such peers have been determined by the Registrant's compensation committee with assistance of an outside consultant immediately prior to the grant date)."}],"balance_after":162567,"source":{"system":"sec-edgar","filing":"0001193125-26-418308","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1633186/000119312526418308/ownership.xml","form_type":"4"}},{"id":4638352,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":29375,"kind":"person","name":"Werner Sean","position":1,"cik":"0002047541","reported_name":"Werner Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2026-10-09T01:54:36.000Z","date":"2026-10-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":69979,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the disposition of shares of common stock (\"Common Stock\") of BioLife Solutions, Inc. (the \"Registrant\") in connection with the consummation on October 6, 2026 of the merger of Bravo Merger Sub I, Inc., a Delaware corporation (\"Merger Sub 1\") with and into the Registrant (the \"First Merger\"), pursuant to the Agreement and Plan of Merger, dated as of July 21, 2026 (the \"Merger Agreement\"), by and among the Registrant, Repligen Corporation, a Delaware corporation (\"Repligen\"), Merger Sub 1 and Bravo Merger Sub II, LLC, a Delaware limited liability company. At the effective time of the First Merger (the \"First Merger Effective Time\"), each outstanding share of Common Stock was converted into the right to receive $11.25 in cash and 0.1442 shares of Repligen common stock, in each case subject to the terms and conditions of the Merger Agreement."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-418304","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2047541/000119312526418304/ownership.xml","form_type":"4"}},{"id":4638351,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":29375,"kind":"person","name":"Werner Sean","position":1,"cik":"0002047541","reported_name":"Werner Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2026-10-09T01:54:36.000Z","date":"2026-10-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":71226,"price":38.61,"value":2750035.86,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents shares withheld to cover tax withholding obligations in connection with the vesting of the market-based restricted stock award."}],"balance_after":24039,"source":{"system":"sec-edgar","filing":"0001193125-26-418304","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2047541/000119312526418304/ownership.xml","form_type":"4"}},{"id":4638350,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":29375,"kind":"person","name":"Werner Sean","position":1,"cik":"0002047541","reported_name":"Werner Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2026-10-09T01:54:36.000Z","date":"2026-10-06","kind":"grant","planned":false,"acquired":true,"shares":48232,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The restricted stock was granted pursuant to the 2023 Plan. In accordance with the terms of the grant and the Merger Agreement, the restricted stock vested immediately prior to the First Merger Effective Time as to approximately 200% of the number of shares granted based on the Registrant's total shareholder return during the period beginning on January 1, 2026 through October 2, 2026 as compared to the total shareholder return of certain of the Registrant's peers (such peers have been determined by the Registrant's compensation committee with assistance of an outside consultant immediately prior to the grant date)."}],"balance_after":95265,"source":{"system":"sec-edgar","filing":"0001193125-26-418304","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2047541/000119312526418304/ownership.xml","form_type":"4"}},{"id":4638349,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":29375,"kind":"person","name":"Werner Sean","position":1,"cik":"0002047541","reported_name":"Werner Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2026-10-09T01:54:36.000Z","date":"2026-10-06","kind":"grant","planned":false,"acquired":true,"shares":45838,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The restricted stock was granted pursuant to the BioLife Solutions 2023 Omnibus Performance Incentive Plan (the \"2023 Plan\"). In accordance with the terms of the grant and the Merger Agreement, the restricted stock vested immediately prior to the First Merger Effective Time as to approximately 200% of the number of shares granted based on the Registrant's total shareholder return during the period beginning on January 1, 2025 through October 2, 2026 as compared to the total shareholder return of certain of the Registrant's peers (such peers have been determined by the Registrant's compensation committee with assistance of an outside consultant immediately prior to the grant date)."}],"balance_after":47033,"source":{"system":"sec-edgar","filing":"0001193125-26-418304","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2047541/000119312526418304/ownership.xml","form_type":"4"}},{"id":4624848,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30885,"kind":"person","name":"Berard Todd","position":1,"cik":"0001633186","reported_name":"Berard Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Marketing Officer"}}],"security":"Common Stock","published_at":"2026-09-22T21:11:58.000Z","date":"2026-09-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":470,"price":36.69,"value":17244.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units."}],"balance_after":161823,"source":{"system":"sec-edgar","filing":"0001628280-26-063079","document":"wk-form4_1790111515.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1633186/000162828026063079/wk-form4_1790111515.xml","form_type":"4"}},{"id":4624849,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30886,"kind":"person","name":"Mathew Aby J.","position":1,"cik":"0001556355","reported_name":"Mathew Aby J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-09-22T21:11:52.000Z","date":"2026-09-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":564,"price":36.69,"value":20693.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units."}],"balance_after":387269,"source":{"system":"sec-edgar","filing":"0001628280-26-063078","document":"wk-form4_1790111510.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1556355/000162828026063078/wk-form4_1790111510.xml","form_type":"4"}},{"id":4624846,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":29375,"kind":"person","name":"Werner Sean","position":1,"cik":"0002047541","reported_name":"Werner Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2026-09-22T21:11:47.000Z","date":"2026-09-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":421,"price":36.69,"value":15446.49,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units."}],"balance_after":47135,"source":{"system":"sec-edgar","filing":"0001628280-26-063077","document":"wk-form4_1790111504.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2047541/000162828026063077/wk-form4_1790111504.xml","form_type":"4"}},{"id":4624845,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":36550,"kind":"person","name":"DE GREEF RODERICK","position":1,"cik":"0001241181","reported_name":"DE GREEF RODERICK","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-09-22T21:11:41.000Z","date":"2026-09-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":2775,"price":36.69,"value":101814.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units."}],"balance_after":728196,"source":{"system":"sec-edgar","filing":"0001628280-26-063076","document":"wk-form4_1790111498.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1241181/000162828026063076/wk-form4_1790111498.xml","form_type":"4"}},{"id":4624847,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-09-22T21:11:33.000Z","date":"2026-09-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":937,"price":36.69,"value":34378.53,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units."}],"balance_after":211286,"source":{"system":"sec-edgar","filing":"0001628280-26-063075","document":"wk-form4_1790111490.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1892616/000162828026063075/wk-form4_1790111490.xml","form_type":"4"}},{"id":4614849,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30885,"kind":"person","name":"Berard Todd","position":1,"cik":"0001633186","reported_name":"Berard Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Marketing Officer"}}],"security":"Common Stock","published_at":"2026-09-10T20:50:42.000Z","date":"2026-09-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":356,"price":35.38,"value":12595.28,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units."}],"balance_after":162293,"source":{"system":"sec-edgar","filing":"0001628280-26-061389","document":"wk-form4_1789073439.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1633186/000162828026061389/wk-form4_1789073439.xml","form_type":"4"}},{"id":4614847,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30886,"kind":"person","name":"Mathew Aby J.","position":1,"cik":"0001556355","reported_name":"Mathew Aby J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-09-10T20:50:34.000Z","date":"2026-09-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":627,"price":35.38,"value":22183.26,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units."}],"balance_after":387833,"source":{"system":"sec-edgar","filing":"0001628280-26-061388","document":"wk-form4_1789073432.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1556355/000162828026061388/wk-form4_1789073432.xml","form_type":"4"}},{"id":4614848,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-09-10T20:50:26.000Z","date":"2026-09-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":1026,"price":35.38,"value":36299.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units."}],"balance_after":212223,"source":{"system":"sec-edgar","filing":"0001628280-26-061387","document":"wk-form4_1789073424.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1892616/000162828026061387/wk-form4_1789073424.xml","form_type":"4"}},{"id":705391,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":29375,"kind":"person","name":"Werner Sean","position":1,"cik":"0002047541","reported_name":"Werner Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2026-07-21T22:47:39.000Z","date":"2026-07-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":275,"price":29.15,"value":8016.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units."}],"balance_after":47556,"source":{"system":"sec-edgar","filing":"0001628280-26-049086","document":"wk-form4_1784674056.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828026049086/wk-form4_1784674056.xml","form_type":"4"}},{"id":710886,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-07-13T21:03:37.000Z","date":"2026-07-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":844,"price":27.79,"value":23454.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units."}],"balance_after":213249,"source":{"system":"sec-edgar","filing":"0001628280-26-048054","document":"wk-form4_1783976614.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828026048054/wk-form4_1783976614.xml","form_type":"4"}},{"id":710885,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30886,"kind":"person","name":"Mathew Aby J.","position":1,"cik":"0001556355","reported_name":"Mathew Aby J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-07-13T21:03:28.000Z","date":"2026-07-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":516,"price":27.79,"value":14339.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units."}],"balance_after":388460,"source":{"system":"sec-edgar","filing":"0001628280-26-048053","document":"wk-form4_1783976605.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828026048053/wk-form4_1783976605.xml","form_type":"4"}},{"id":710884,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30885,"kind":"person","name":"Berard Todd","position":1,"cik":"0001633186","reported_name":"Berard Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Marketing Officer"}}],"security":"Common Stock","published_at":"2026-07-13T21:03:20.000Z","date":"2026-07-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":293,"price":27.79,"value":8142.47,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units."}],"balance_after":162649,"source":{"system":"sec-edgar","filing":"0001628280-26-048052","document":"wk-form4_1783976597.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828026048052/wk-form4_1783976597.xml","form_type":"4"}},{"id":731238,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30885,"kind":"person","name":"Berard Todd","position":1,"cik":"0001633186","reported_name":"Berard Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Marketing Officer"}}],"security":"Common Stock","published_at":"2026-06-22T20:50:32.000Z","date":"2026-06-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":470,"price":26.04,"value":12238.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units."}],"balance_after":162942,"source":{"system":"sec-edgar","filing":"0001628280-26-044699","document":"wk-form4_1782161430.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828026044699/wk-form4_1782161430.xml","form_type":"4"}},{"id":731239,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":29375,"kind":"person","name":"Werner Sean","position":1,"cik":"0002047541","reported_name":"Werner Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2026-06-22T20:50:26.000Z","date":"2026-06-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":420,"price":26.04,"value":10936.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units."}],"balance_after":47831,"source":{"system":"sec-edgar","filing":"0001628280-26-044698","document":"wk-form4_1782161424.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828026044698/wk-form4_1782161424.xml","form_type":"4"}},{"id":731237,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":36550,"kind":"person","name":"DE GREEF RODERICK","position":1,"cik":"0001241181","reported_name":"DE GREEF RODERICK","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-06-22T20:50:19.000Z","date":"2026-06-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":2775,"price":26.04,"value":72261.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units."}],"balance_after":730971,"source":{"system":"sec-edgar","filing":"0001628280-26-044696","document":"wk-form4_1782161414.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828026044696/wk-form4_1782161414.xml","form_type":"4"}},{"id":731236,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-22T20:50:08.000Z","date":"2026-06-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":937,"price":26.04,"value":24399.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units."}],"balance_after":214093,"source":{"system":"sec-edgar","filing":"0001628280-26-044695","document":"wk-form4_1782161406.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828026044695/wk-form4_1782161406.xml","form_type":"4"}},{"id":731235,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30886,"kind":"person","name":"Mathew Aby J.","position":1,"cik":"0001556355","reported_name":"Mathew Aby J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-06-22T20:50:00.000Z","date":"2026-06-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":564,"price":26.04,"value":14686.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units."}],"balance_after":388976,"source":{"system":"sec-edgar","filing":"0001628280-26-044694","document":"wk-form4_1782161398.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828026044694/wk-form4_1782161398.xml","form_type":"4"}},{"id":743887,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-10T21:01:33.000Z","date":"2026-06-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":1026,"price":26.1,"value":26778.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units."}],"balance_after":215030,"source":{"system":"sec-edgar","filing":"0001628280-26-042286","document":"wk-form4_1781125288.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828026042286/wk-form4_1781125288.xml","form_type":"4"}},{"id":743886,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30885,"kind":"person","name":"Berard Todd","position":1,"cik":"0001633186","reported_name":"Berard Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Marketing Officer"}}],"security":"Common Stock","published_at":"2026-06-10T21:01:25.000Z","date":"2026-06-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":356,"price":26.1,"value":9291.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units."}],"balance_after":163412,"source":{"system":"sec-edgar","filing":"0001628280-26-042285","document":"wk-form4_1781125282.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828026042285/wk-form4_1781125282.xml","form_type":"4"}},{"id":743885,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30886,"kind":"person","name":"Mathew Aby J.","position":1,"cik":"0001556355","reported_name":"Mathew Aby J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-06-10T21:01:19.000Z","date":"2026-06-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":627,"price":26.1,"value":16364.7,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units."}],"balance_after":389540,"source":{"system":"sec-edgar","filing":"0001628280-26-042284","document":"wk-form4_1781125276.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828026042284/wk-form4_1781125276.xml","form_type":"4"}},{"id":769059,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":40532,"kind":"person","name":"Casdin Partners Master Fund, L.P.","position":1,"cik":"0001534265","reported_name":"Casdin Partners Master Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40531,"kind":"person","name":"Casdin Capital, LLC","position":2,"cik":"0001534261","reported_name":"Casdin Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40533,"kind":"person","name":"Casdin Partners GP, LLC","position":3,"cik":"0001534260","reported_name":"Casdin Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36006,"kind":"person","name":"Casdin Eli","position":4,"cik":"0001534264","reported_name":"Casdin Eli","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2026-05-21T23:10:04.000Z","date":"2026-05-21","kind":"sale","planned":false,"acquired":false,"shares":650000,"price":23.7,"value":15405000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities are owned directly by Casdin Partners Master Fund, L.P. (the \"Master Fund\") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC (\"Casdin Capital\"), the investment adviser to the Master Fund, (ii) Casdin Partners GP, LLC (\"Casdin GP\"), the general partner of the Master Fund, and (iii) Eli Casdin, the managing member of Casdin Capital and Casdin GP."}],"balance_after":4757165,"source":{"system":"sec-edgar","filing":"0000919574-26-003646","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/834365/000091957426003646/ownership.xml","form_type":"4"}},{"id":769058,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":40532,"kind":"person","name":"Casdin Partners Master Fund, L.P.","position":1,"cik":"0001534265","reported_name":"Casdin Partners Master Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40531,"kind":"person","name":"Casdin Capital, LLC","position":2,"cik":"0001534261","reported_name":"Casdin Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40533,"kind":"person","name":"Casdin Partners GP, LLC","position":3,"cik":"0001534260","reported_name":"Casdin Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36006,"kind":"person","name":"Casdin Eli","position":4,"cik":"0001534264","reported_name":"Casdin Eli","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2026-05-21T23:10:04.000Z","date":"2026-05-20","kind":"sale","planned":false,"acquired":false,"shares":250000,"price":23.7,"value":5925000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities are owned directly by Casdin Partners Master Fund, L.P. (the \"Master Fund\") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC (\"Casdin Capital\"), the investment adviser to the Master Fund, (ii) Casdin Partners GP, LLC (\"Casdin GP\"), the general partner of the Master Fund, and (iii) Eli Casdin, the managing member of Casdin Capital and Casdin GP."}],"balance_after":5407165,"source":{"system":"sec-edgar","filing":"0000919574-26-003646","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/834365/000091957426003646/ownership.xml","form_type":"4"}},{"id":769057,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":40532,"kind":"person","name":"Casdin Partners Master Fund, L.P.","position":1,"cik":"0001534265","reported_name":"Casdin Partners Master Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40531,"kind":"person","name":"Casdin Capital, LLC","position":2,"cik":"0001534261","reported_name":"Casdin Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40533,"kind":"person","name":"Casdin Partners GP, LLC","position":3,"cik":"0001534260","reported_name":"Casdin Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36006,"kind":"person","name":"Casdin Eli","position":4,"cik":"0001534264","reported_name":"Casdin Eli","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2026-05-21T23:10:04.000Z","date":"2026-05-19","kind":"sale","planned":false,"acquired":false,"shares":300000,"price":22.65,"value":6795000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities are owned directly by Casdin Partners Master Fund, L.P. (the \"Master Fund\") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC (\"Casdin Capital\"), the investment adviser to the Master Fund, (ii) Casdin Partners GP, LLC (\"Casdin GP\"), the general partner of the Master Fund, and (iii) Eli Casdin, the managing member of Casdin Capital and Casdin GP."}],"balance_after":5657165,"source":{"system":"sec-edgar","filing":"0000919574-26-003646","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000091957426003646/ownership.xml","form_type":"4"}},{"id":810866,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30886,"kind":"person","name":"Mathew Aby J.","position":1,"cik":"0001556355","reported_name":"Mathew Aby J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-04-10T21:29:29.000Z","date":"2026-04-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":515,"price":19.27,"value":9924.05,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units."}],"balance_after":390167,"source":{"system":"sec-edgar","filing":"0001628280-26-024767","document":"wk-form4_1775856566.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828026024767/wk-form4_1775856566.xml","form_type":"4"}},{"id":810865,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30885,"kind":"person","name":"Berard Todd","position":1,"cik":"0001633186","reported_name":"Berard Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Marketing Officer"}}],"security":"Common Stock","published_at":"2026-04-10T21:29:20.000Z","date":"2026-04-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":293,"price":19.27,"value":5646.11,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units."}],"balance_after":163768,"source":{"system":"sec-edgar","filing":"0001628280-26-024766","document":"wk-form4_1775856558.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828026024766/wk-form4_1775856558.xml","form_type":"4"}},{"id":810863,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-04-10T21:29:11.000Z","date":"2026-04-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":844,"price":19.27,"value":16263.88,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units."}],"balance_after":216056,"source":{"system":"sec-edgar","filing":"0001628280-26-024765","document":"wk-form4_1775856548.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828026024765/wk-form4_1775856548.xml","form_type":"4"}},{"id":824777,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":55204,"kind":"person","name":"Foster Karen A.","position":1,"cik":"0001683151","reported_name":"Foster Karen A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Quality and Operations"}}],"security":"Common Stock","published_at":"2026-03-31T21:19:44.000Z","date":"2026-03-23","kind":"sale","planned":true,"acquired":false,"shares":2577,"price":19.17,"value":49401.09,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 12-04-2025"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.99 to $19.35, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":108758,"source":{"system":"sec-edgar","filing":"0001628280-26-022501","document":"wk-form4_1774991982.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828026022501/wk-form4_1774991982.xml","form_type":"4"}},{"id":831556,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":36550,"kind":"person","name":"DE GREEF RODERICK","position":1,"cik":"0001241181","reported_name":"DE GREEF RODERICK","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-03-23T21:09:09.000Z","date":"2026-03-19","kind":"tax_withholding","planned":false,"acquired":false,"shares":11101,"price":19.12,"value":212251.12,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units."}],"balance_after":733746,"source":{"system":"sec-edgar","filing":"0001628280-26-020581","document":"wk-form4_1774300146.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828026020581/wk-form4_1774300146.xml","form_type":"4"}},{"id":831555,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30885,"kind":"person","name":"Berard Todd","position":1,"cik":"0001633186","reported_name":"Berard Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Marketing Officer"}}],"security":"Common Stock","published_at":"2026-03-23T21:09:03.000Z","date":"2026-03-19","kind":"tax_withholding","planned":false,"acquired":false,"shares":1879,"price":19.12,"value":35926.48,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units."}],"balance_after":164061,"source":{"system":"sec-edgar","filing":"0001628280-26-020580","document":"wk-form4_1774300140.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828026020580/wk-form4_1774300140.xml","form_type":"4"}},{"id":831554,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":29375,"kind":"person","name":"Werner Sean","position":1,"cik":"0002047541","reported_name":"Werner Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2026-03-23T21:08:55.000Z","date":"2026-03-19","kind":"tax_withholding","planned":false,"acquired":false,"shares":1681,"price":19.12,"value":32140.72,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units."}],"balance_after":48251,"source":{"system":"sec-edgar","filing":"0001628280-26-020579","document":"wk-form4_1774300132.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828026020579/wk-form4_1774300132.xml","form_type":"4"}},{"id":831553,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-23T21:08:47.000Z","date":"2026-03-19","kind":"tax_withholding","planned":false,"acquired":false,"shares":3749,"price":19.12,"value":71680.88,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units."}],"balance_after":216900,"source":{"system":"sec-edgar","filing":"0001628280-26-020578","document":"wk-form4_1774300124.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828026020578/wk-form4_1774300124.xml","form_type":"4"}},{"id":831552,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":56695,"kind":"person","name":"Aebersold Sarah","position":1,"cik":"0001837756","reported_name":"Aebersold Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2026-03-23T21:08:39.000Z","date":"2026-03-19","kind":"tax_withholding","planned":false,"acquired":false,"shares":931,"price":19.12,"value":17800.72,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units."}],"balance_after":92429,"source":{"system":"sec-edgar","filing":"0001628280-26-020577","document":"wk-form4_1774300116.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828026020577/wk-form4_1774300116.xml","form_type":"4"}},{"id":831551,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":55204,"kind":"person","name":"Foster Karen A.","position":1,"cik":"0001683151","reported_name":"Foster Karen A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Quality and Operations"}}],"security":"Common Stock","published_at":"2026-03-23T21:08:33.000Z","date":"2026-03-19","kind":"tax_withholding","planned":false,"acquired":false,"shares":1907,"price":19.12,"value":36461.84,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units."}],"balance_after":111335,"source":{"system":"sec-edgar","filing":"0001628280-26-020576","document":"wk-form4_1774300110.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828026020576/wk-form4_1774300110.xml","form_type":"4"}},{"id":831550,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30886,"kind":"person","name":"Mathew Aby J.","position":1,"cik":"0001556355","reported_name":"Mathew Aby J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-03-23T21:08:25.000Z","date":"2026-03-19","kind":"tax_withholding","planned":false,"acquired":false,"shares":2255,"price":19.12,"value":43115.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units."}],"balance_after":390682,"source":{"system":"sec-edgar","filing":"0001628280-26-020574","document":"wk-form4_1774300102.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828026020574/wk-form4_1774300102.xml","form_type":"4"}},{"id":854879,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":55204,"kind":"person","name":"Foster Karen A.","position":1,"cik":"0001683151","reported_name":"Foster Karen A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Quality and Operations"}}],"security":"Common Stock","published_at":"2026-03-09T22:11:01.000Z","date":"2026-03-09","kind":"sale","planned":false,"acquired":false,"shares":500,"price":20,"value":10000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.02, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":113242,"source":{"system":"sec-edgar","filing":"0001628280-26-016165","document":"wk-form4_1773094257.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828026016165/wk-form4_1773094257.xml","form_type":"4"}},{"id":854878,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":55204,"kind":"person","name":"Foster Karen A.","position":1,"cik":"0001683151","reported_name":"Foster Karen A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Quality and Operations"}}],"security":"Common Stock","published_at":"2026-03-09T22:11:01.000Z","date":"2026-03-05","kind":"sale","planned":false,"acquired":false,"shares":96923,"price":20.15,"value":1952998.45,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.46, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":113742,"source":{"system":"sec-edgar","filing":"0001628280-26-016165","document":"wk-form4_1773094257.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828026016165/wk-form4_1773094257.xml","form_type":"4"}},{"id":859866,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":29375,"kind":"person","name":"Werner Sean","position":1,"cik":"0002047541","reported_name":"Werner Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2026-03-05T22:10:35.000Z","date":"2026-03-03","kind":"sale","planned":true,"acquired":false,"shares":111,"price":20.74,"value":2302.14,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":49932,"source":{"system":"sec-edgar","filing":"0001628280-26-015342","document":"wk-form4_1772748632.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828026015342/wk-form4_1772748632.xml","form_type":"4"}},{"id":859865,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":55204,"kind":"person","name":"Foster Karen A.","position":1,"cik":"0001683151","reported_name":"Foster Karen A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Quality and Operations"}}],"security":"Common Stock","published_at":"2026-03-05T22:10:29.000Z","date":"2026-03-03","kind":"sale","planned":true,"acquired":false,"shares":418,"price":20.74,"value":8669.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":210665,"source":{"system":"sec-edgar","filing":"0001628280-26-015341","document":"wk-form4_1772748626.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828026015341/wk-form4_1772748626.xml","form_type":"4"}},{"id":859864,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30886,"kind":"person","name":"Mathew Aby J.","position":1,"cik":"0001556355","reported_name":"Mathew Aby J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-03-05T22:10:23.000Z","date":"2026-03-03","kind":"sale","planned":true,"acquired":false,"shares":529,"price":20.74,"value":10971.46,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":392937,"source":{"system":"sec-edgar","filing":"0001628280-26-015340","document":"wk-form4_1772748620.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828026015340/wk-form4_1772748620.xml","form_type":"4"}},{"id":859863,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-05T22:10:17.000Z","date":"2026-03-03","kind":"sale","planned":true,"acquired":false,"shares":588,"price":20.74,"value":12195.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":220649,"source":{"system":"sec-edgar","filing":"0001628280-26-015339","document":"wk-form4_1772748614.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828026015339/wk-form4_1772748614.xml","form_type":"4"}},{"id":859862,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":56695,"kind":"person","name":"Aebersold Sarah","position":1,"cik":"0001837756","reported_name":"Aebersold Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2026-03-05T22:10:11.000Z","date":"2026-03-03","kind":"sale","planned":true,"acquired":false,"shares":219,"price":20.74,"value":4542.06,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":93360,"source":{"system":"sec-edgar","filing":"0001628280-26-015337","document":"wk-form4_1772748608.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828026015337/wk-form4_1772748608.xml","form_type":"4"}},{"id":859859,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30885,"kind":"person","name":"Berard Todd","position":1,"cik":"0001633186","reported_name":"Berard Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Marketing Officer"}}],"security":"Common Stock","published_at":"2026-03-05T22:10:05.000Z","date":"2026-03-03","kind":"sale","planned":true,"acquired":false,"shares":353,"price":20.74,"value":7321.22,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":165940,"source":{"system":"sec-edgar","filing":"0001628280-26-015336","document":"wk-form4_1772748602.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828026015336/wk-form4_1772748602.xml","form_type":"4"}},{"id":880809,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30885,"kind":"person","name":"Berard Todd","position":1,"cik":"0001633186","reported_name":"Berard Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Marketing Officer"}}],"security":"Common Stock","published_at":"2026-02-26T22:56:18.000Z","date":"2026-02-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":8846,"price":22.65,"value":200361.9,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents shares withheld to cover tax withholding obligations in connection with the vesting of the market-based restricted stock award."}],"balance_after":166293,"source":{"system":"sec-edgar","filing":"0001628280-26-012481","document":"wk-form4_1772146575.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828026012481/wk-form4_1772146575.xml","form_type":"4"}},{"id":880808,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30885,"kind":"person","name":"Berard Todd","position":1,"cik":"0001633186","reported_name":"Berard Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Marketing Officer"}}],"security":"Common Stock","published_at":"2026-02-26T22:56:18.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":22479,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The restricted stock was granted pursuant to the 2023 Plan. In accordance with the terms of the grant, the restricted stock vested as to approximately 156% of the number of shares granted based on the registrant's total shareholder return during the period beginning on January 1, 2024 through December 31, 2025 as compared to the total shareholder return of certain of the registrant's peers (such peers have been determined by the registrant's compensation committee with assistance of an outside consultant immediately prior to the grant date)."}],"balance_after":175139,"source":{"system":"sec-edgar","filing":"0001628280-26-012481","document":"wk-form4_1772146575.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828026012481/wk-form4_1772146575.xml","form_type":"4"}},{"id":880807,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30885,"kind":"person","name":"Berard Todd","position":1,"cik":"0001633186","reported_name":"Berard Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Marketing Officer"}}],"security":"Common Stock","published_at":"2026-02-26T22:56:18.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":20096,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock was granted pursuant to the BioLife Solutions 2023 Omnibus Performance Incentive Plan (the \"2023 Plan\") and vests 25% on the first anniversary of the grant date and thereafter quarterly, in 12 equal quarterly installments. The restricted stock was granted to the reporting person as part of 2026 compensation."}],"balance_after":152660,"source":{"system":"sec-edgar","filing":"0001628280-26-012481","document":"wk-form4_1772146575.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828026012481/wk-form4_1772146575.xml","form_type":"4"}},{"id":880794,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":64611,"kind":"person","name":"DuRoss Amy","position":1,"cik":"0001854968","reported_name":"DuRoss Amy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-26T22:56:12.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":8170,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock was granted pursuant to the BioLife Solutions 2023 Performance Incentive Plan and fully vests on the first anniversary of the vesting date of January 2, 2026"}],"balance_after":26857,"source":{"system":"sec-edgar","filing":"0001628280-26-012480","document":"wk-form4_1772146569.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828026012480/wk-form4_1772146569.xml","form_type":"4"}},{"id":880793,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-26T22:56:06.000Z","date":"2026-02-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":25525,"price":22.65,"value":578141.25,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents shares withheld to cover tax withholding obligations in connection with the vesting of the market-based restricted stock award."}],"balance_after":221237,"source":{"system":"sec-edgar","filing":"0001628280-26-012479","document":"wk-form4_1772146564.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828026012479/wk-form4_1772146564.xml","form_type":"4"}},{"id":880792,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-26T22:56:06.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":64866,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The restricted stock was granted pursuant to the 2023 Plan. In accordance with the terms of the grant, the restricted stock vested as to approximately 156% of the number of shares granted based on the registrant's total shareholder return during the period beginning on January 1, 2024 through December 31, 2025 as compared to the total shareholder return of certain of the registrant's peers (such peers have been determined by the registrant's compensation committee with assistance of an outside consultant immediately prior to the grant date)."}],"balance_after":246762,"source":{"system":"sec-edgar","filing":"0001628280-26-012479","document":"wk-form4_1772146564.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828026012479/wk-form4_1772146564.xml","form_type":"4"}},{"id":880791,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-26T22:56:06.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":31150,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock was granted pursuant to the BioLife Solutions 2023 Omnibus Performance Incentive Plan (the \"2023 Plan\") and vests 25% on the first anniversary of the grant date and thereafter quarterly, in 12 equal quarterly installments. The restricted stock was granted to the reporting person as part of 2026 compensation."}],"balance_after":181896,"source":{"system":"sec-edgar","filing":"0001628280-26-012479","document":"wk-form4_1772146564.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828026012479/wk-form4_1772146564.xml","form_type":"4"}},{"id":880789,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":38580,"kind":"person","name":"Hunt Anthony","position":1,"cik":"0001606030","reported_name":"Hunt Anthony","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-26T22:56:00.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":8170,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock was granted pursuant to the BioLife Solutions 2023 Performance Incentive Plan and fully vests on the first anniversary of the vesting date of January 2, 2026"}],"balance_after":15046,"source":{"system":"sec-edgar","filing":"0001628280-26-012478","document":"wk-form4_1772146558.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828026012478/wk-form4_1772146558.xml","form_type":"4"}},{"id":880790,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":64610,"kind":"person","name":"Coste Catherine","position":1,"cik":"0001821432","reported_name":"Coste Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-26T22:55:54.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":8170,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock was granted pursuant to the BioLife Solutions 2023 Performance Incentive Plan and fully vests on the first anniversary of the vesting date of January 2, 2026."}],"balance_after":13871,"source":{"system":"sec-edgar","filing":"0001628280-26-012477","document":"wk-form4_1772146552.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828026012477/wk-form4_1772146552.xml","form_type":"4"}},{"id":880788,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":64609,"kind":"person","name":"Ellingson Rachel","position":1,"cik":"0001557271","reported_name":"Ellingson Rachel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-26T22:55:49.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":8170,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock was granted pursuant to the BioLife Solutions 2023 Performance Incentive Plan and fully vests on the first anniversary of the vesting date of January 2, 2026"}],"balance_after":57995,"source":{"system":"sec-edgar","filing":"0001628280-26-012476","document":"wk-form4_1772146544.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828026012476/wk-form4_1772146544.xml","form_type":"4"}},{"id":880787,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":36550,"kind":"person","name":"DE GREEF RODERICK","position":1,"cik":"0001241181","reported_name":"DE GREEF RODERICK","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-02-26T22:55:41.000Z","date":"2026-02-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":86186,"price":22.65,"value":1952112.9,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents shares withheld to cover tax withholding obligations in connection with the vesting of the performance-based restricted stock award."}],"balance_after":744847,"source":{"system":"sec-edgar","filing":"0001628280-26-012474","document":"wk-form4_1772146538.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828026012474/wk-form4_1772146538.xml","form_type":"4"}},{"id":880786,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":36550,"kind":"person","name":"DE GREEF RODERICK","position":1,"cik":"0001241181","reported_name":"DE GREEF RODERICK","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-02-26T22:55:41.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":219024,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The restricted stock was granted pursuant to the 2023 Plan. In accordance with the terms of the grant, the restricted stock vested as to 200% of the number of shares granted based on specific performance metrics of the registrant during the period beginning on January 1, 2024 through December 31, 2025."}],"balance_after":831033,"source":{"system":"sec-edgar","filing":"0001628280-26-012474","document":"wk-form4_1772146538.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828026012474/wk-form4_1772146538.xml","form_type":"4"}},{"id":880785,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":36550,"kind":"person","name":"DE GREEF RODERICK","position":1,"cik":"0001241181","reported_name":"DE GREEF RODERICK","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-02-26T22:55:41.000Z","date":"2026-02-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":67010,"price":22.65,"value":1517776.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents shares withheld to cover tax withholding obligations in connection with the vesting of the market-based restricted stock award."}],"balance_after":612009,"source":{"system":"sec-edgar","filing":"0001628280-26-012474","document":"wk-form4_1772146538.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828026012474/wk-form4_1772146538.xml","form_type":"4"}},{"id":880784,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":36550,"kind":"person","name":"DE GREEF RODERICK","position":1,"cik":"0001241181","reported_name":"DE GREEF RODERICK","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-02-26T22:55:41.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":170291,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The restricted stock was granted pursuant to the 2023 Plan. In accordance with the terms of the grant, the restricted stock vested as to approximately 156% of the number of shares granted based on the registrant's total shareholder return during the period beginning on January 1, 2024 through December 31, 2025 as compared to the total shareholder return of certain of the registrant's peers (such peers have been determined by the registrant's compensation committee with assistance of an outside consultant immediately prior to the grant date)."}],"balance_after":679019,"source":{"system":"sec-edgar","filing":"0001628280-26-012474","document":"wk-form4_1772146538.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828026012474/wk-form4_1772146538.xml","form_type":"4"}},{"id":880783,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":36550,"kind":"person","name":"DE GREEF RODERICK","position":1,"cik":"0001241181","reported_name":"DE GREEF RODERICK","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-02-26T22:55:41.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":118730,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock was granted pursuant to the BioLife Solutions 2023 Omnibus Performance Incentive Plan (the \"2023 Plan\") and vests 25% on the first anniversary of the grant date and thereafter quarterly, in 12 equal quarterly installments. The restricted stock was granted to the reporting person as part of 2026 compensation."}],"balance_after":508728,"source":{"system":"sec-edgar","filing":"0001628280-26-012474","document":"wk-form4_1772146538.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828026012474/wk-form4_1772146538.xml","form_type":"4"}},{"id":880782,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30886,"kind":"person","name":"Mathew Aby J.","position":1,"cik":"0001556355","reported_name":"Mathew Aby J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-02-26T22:55:35.000Z","date":"2026-02-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":15585,"price":22.65,"value":353000.25,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents shares withheld to cover tax withholding obligations in connection with the vesting of the market-based restricted stock award."}],"balance_after":393466,"source":{"system":"sec-edgar","filing":"0001628280-26-012473","document":"wk-form4_1772146532.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828026012473/wk-form4_1772146532.xml","form_type":"4"}},{"id":880781,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30886,"kind":"person","name":"Mathew Aby J.","position":1,"cik":"0001556355","reported_name":"Mathew Aby J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-02-26T22:55:35.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":39605,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The restricted stock was granted pursuant to the 2023 Plan. In accordance with the terms of the grant, the restricted stock vested as to approximately 156% of the number of shares granted based on the registrant's total shareholder return during the period beginning on January 1, 2024 through December 31, 2025 as compared to the total shareholder return of certain of the registrant's peers (such peers have been determined by the registrant's compensation committee with assistance of an outside consultant immediately prior to the grant date)."}],"balance_after":409051,"source":{"system":"sec-edgar","filing":"0001628280-26-012473","document":"wk-form4_1772146532.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828026012473/wk-form4_1772146532.xml","form_type":"4"}},{"id":880780,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30886,"kind":"person","name":"Mathew Aby J.","position":1,"cik":"0001556355","reported_name":"Mathew Aby J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-02-26T22:55:35.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":20096,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock was granted pursuant to the BioLife Solutions 2023 Omnibus Performance Incentive Plan (the \"2023 Plan\") and vests 25% on the first anniversary of the grant date and thereafter quarterly, in 12 equal quarterly installments. The restricted stock was granted to the reporting person as part of 2026 compensation."}],"balance_after":369446,"source":{"system":"sec-edgar","filing":"0001628280-26-012473","document":"wk-form4_1772146532.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828026012473/wk-form4_1772146532.xml","form_type":"4"}},{"id":880779,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":56695,"kind":"person","name":"Aebersold Sarah","position":1,"cik":"0001837756","reported_name":"Aebersold Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2026-02-26T22:55:29.000Z","date":"2026-02-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":5734,"price":22.65,"value":129875.1,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents shares withheld to cover tax withholding obligations in connection with the vesting of the market-based restricted stock award."}],"balance_after":93579,"source":{"system":"sec-edgar","filing":"0001628280-26-012472","document":"wk-form4_1772146526.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828026012472/wk-form4_1772146526.xml","form_type":"4"}},{"id":880778,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":56695,"kind":"person","name":"Aebersold Sarah","position":1,"cik":"0001837756","reported_name":"Aebersold Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2026-02-26T22:55:29.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":23548,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock was granted pursuant to the BioLife Solutions 2023 Omnibus Performance Incentive Plan. In accordance with the terms of the grant, the restricted stock vested as to approximately 156% of the number of shares granted based on the registrant's total shareholder return during the period beginning on January 1, 2024 through December 31, 2025 as compared to the total shareholder return of certain of the registrant's peers (such peers have been determined by the registrant's compensation committee with assistance of an outside consultant immediately prior to the grant date)."}],"balance_after":99313,"source":{"system":"sec-edgar","filing":"0001628280-26-012472","document":"wk-form4_1772146526.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828026012472/wk-form4_1772146526.xml","form_type":"4"}},{"id":880777,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":29375,"kind":"person","name":"Werner Sean","position":1,"cik":"0002047541","reported_name":"Werner Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2026-02-26T22:55:23.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":24116,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock was granted pursuant to the BioLife Solutions 2023 Omnibus Performance Incentive Plan and vests 25% on the first anniversary of the grant date and thereafter quarterly, in 12 equal quarterly installments. The restricted stock was granted to the reporting person as part of 2026 compensation."}],"balance_after":50043,"source":{"system":"sec-edgar","filing":"0001628280-26-012471","document":"wk-form4_1772146521.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828026012471/wk-form4_1772146521.xml","form_type":"4"}},{"id":880776,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":64608,"kind":"person","name":"MOORE TIMOTHY L.","position":1,"cik":"0001669207","reported_name":"MOORE TIMOTHY L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-26T22:55:17.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":8170,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock was granted pursuant to the BioLife Solutions 2023 Performance Incentive Plan and fully vests on the first anniversary of the vesting date of January 2, 2026"}],"balance_after":44943,"source":{"system":"sec-edgar","filing":"0001628280-26-012470","document":"wk-form4_1772146515.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828026012470/wk-form4_1772146515.xml","form_type":"4"}},{"id":880775,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":55204,"kind":"person","name":"Foster Karen A.","position":1,"cik":"0001683151","reported_name":"Foster Karen A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Quality and Operations"}}],"security":"Common Stock","published_at":"2026-02-26T22:55:11.000Z","date":"2026-02-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":13013,"price":22.65,"value":294744.45,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents shares withheld to cover tax withholding obligations in connection with the vesting of the market-based restricted stock award."}],"balance_after":211083,"source":{"system":"sec-edgar","filing":"0001628280-26-012469","document":"wk-form4_1772146509.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828026012469/wk-form4_1772146509.xml","form_type":"4"}},{"id":880774,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":55204,"kind":"person","name":"Foster Karen A.","position":1,"cik":"0001683151","reported_name":"Foster Karen A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Quality and Operations"}}],"security":"Common Stock","published_at":"2026-02-26T22:55:11.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":32112,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock was granted pursuant to the BioLife Solutions 2023 Omnibus Performance Incentive Plan. In accordance with the terms of the grant, the restricted stock vested as to approximately 156% of the number of shares granted based on the registrant's total shareholder return during the period beginning on January 1, 2024 through December 31, 2025 as compared to the total shareholder return of certain of the registrant's peers (such peers have been determined by the registrant's compensation committee with assistance of an outside consultant immediately prior to the grant date)."}],"balance_after":224096,"source":{"system":"sec-edgar","filing":"0001628280-26-012469","document":"wk-form4_1772146509.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828026012469/wk-form4_1772146509.xml","form_type":"4"}},{"id":880772,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":64607,"kind":"person","name":"GOSWAMI JOYDEEP","position":1,"cik":"0001533115","reported_name":"GOSWAMI JOYDEEP","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-26T22:55:06.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":8170,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock was granted pursuant to the BioLife Solutions 2023 Performance Incentive Plan and fully vests on the first anniversary of the vesting date of January 2, 2026"}],"balance_after":53156,"source":{"system":"sec-edgar","filing":"0001628280-26-012468","document":"wk-form4_1772146503.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828026012468/wk-form4_1772146503.xml","form_type":"4"}},{"id":943691,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-01-08T22:04:31.000Z","date":"2026-01-06","kind":"sale","planned":true,"acquired":false,"shares":990,"price":25.59,"value":25334.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 01-03-2023 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":150746,"source":{"system":"sec-edgar","filing":"0001628280-26-001387","document":"wk-form4_1767909868.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828026001387/wk-form4_1767909868.xml","form_type":"4"}},{"id":943690,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":55204,"kind":"person","name":"Foster Karen A.","position":1,"cik":"0001683151","reported_name":"Foster Karen A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Quality and Operations"}}],"security":"Common Stock","published_at":"2026-01-08T22:04:23.000Z","date":"2026-01-06","kind":"sale","planned":true,"acquired":false,"shares":335,"price":25.59,"value":8572.65,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 01-03-2023 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":191984,"source":{"system":"sec-edgar","filing":"0001628280-26-001385","document":"wk-form4_1767909860.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828026001385/wk-form4_1767909860.xml","form_type":"4"}},{"id":943689,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":56695,"kind":"person","name":"Aebersold Sarah","position":1,"cik":"0001837756","reported_name":"Aebersold Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2026-01-08T22:04:14.000Z","date":"2026-01-06","kind":"sale","planned":true,"acquired":false,"shares":241,"price":25.59,"value":6167.19,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 01-03-2023 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":75765,"source":{"system":"sec-edgar","filing":"0001628280-26-001384","document":"wk-form4_1767909852.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828026001384/wk-form4_1767909852.xml","form_type":"4"}},{"id":943688,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30886,"kind":"person","name":"Mathew Aby J.","position":1,"cik":"0001556355","reported_name":"Mathew Aby J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-01-08T22:04:07.000Z","date":"2026-01-06","kind":"sale","planned":true,"acquired":false,"shares":405,"price":25.59,"value":10363.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 01-03-2023 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":349350,"source":{"system":"sec-edgar","filing":"0001628280-26-001383","document":"wk-form4_1767909839.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828026001383/wk-form4_1767909839.xml","form_type":"4"}},{"id":943687,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30885,"kind":"person","name":"Berard Todd","position":1,"cik":"0001633186","reported_name":"Berard Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Marketing Officer"}}],"security":"Common Stock","published_at":"2026-01-08T22:03:52.000Z","date":"2026-01-06","kind":"sale","planned":true,"acquired":false,"shares":344,"price":25.59,"value":8802.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 01-03-2023 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":132564,"source":{"system":"sec-edgar","filing":"0001628280-26-001382","document":"wk-form4_1767909830.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828026001382/wk-form4_1767909830.xml","form_type":"4"}},{"id":966120,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30886,"kind":"person","name":"Mathew Aby J.","position":1,"cik":"0001556355","reported_name":"Mathew Aby J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-12-17T22:26:20.000Z","date":"2025-12-09","kind":"sale","planned":true,"acquired":false,"shares":631,"price":25.13,"value":15857.03,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 03-08-2024 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":349755,"source":{"system":"sec-edgar","filing":"0001628280-25-057724","document":"wk-form4_1766010377.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828025057724/wk-form4_1766010377.xml","form_type":"4"}},{"id":966119,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":30887,"kind":"person","name":"Wichterman Troy","position":1,"cik":"0001892616","reported_name":"Wichterman Troy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-12-17T22:26:14.000Z","date":"2025-12-09","kind":"sale","planned":true,"acquired":false,"shares":1033,"price":25.13,"value":25959.29,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 03-08-2024 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":151736,"source":{"system":"sec-edgar","filing":"0001628280-25-057723","document":"wk-form4_1766010371.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828025057723/wk-form4_1766010371.xml","form_type":"4"}}],"next_cursor":"2025-12-17T22:26:14.000000Z,966119"}